Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization.
[cholangiocarcinoma]
After
liver
transplantation
for
cholangiocarcinoma
(
CCC
)
,
patients
have
a
poor
prognosis
without
use
of
specific
therapeutic
strategies
.
Accordingly
,
recipients
with
incidental
CCC
might
have
the
highest
risk
of
recurrent
disease
;
however
,
sparse
data
on
the
long
-term
outcome
of
unselected
patients
with
incidental
CCC
have
been
published
.
The
aim
of
this
study
was
to
evaluate
the
post-transplantation
outcomes
of
patients
with
incidental
CCC
with
special
focus
on
tumor
localization
.
There
were
11
primary
liver
transplantations
in
patients
with
incidental
CCC
of
1310
liver
transplantation
procedures
performed
between
December
1994
and
August
2013
.
All
patients
with
incidental
CCC
received
a
chemotherapy
regiment
including
gemcitabine
/
5
fluorouracil
,
doxorubicin
,
and
mitomycin
.
The
patients
were
switched
from
calcineurin
inhibitors
to
mammalian
target
of
rapamycin
inhibitor-based
immunosuppression
shortly
after
CCC
diagnosis
.
Intra-
and
extrahepatic
tumors
were
found
in
6
and
5
patients
,
respectively
.
At
median
follow-up
examination
of
26
.
3
months
there
were
8
CCC
recurrences
and
7
patient
deaths
.
Overall
survival
after
liver
transplantation
for
incidental
CCC
was
88
.
9
%
at
1
year
,
44
.
4
%
at
2
years
,
and
14
.
8
%
at
3
years
.
The
corresponding
rates
of
recurrence-free
survival
were
45
.
7
%
,
45
.
7
%
,
and
0
.
0
%
,
respectively
.
Post-transplantation
CCC
recurrences
were
universal
with
0
%
3
-
year
recurrence-free
survival
both
in
patients
with
intra-
and
extrahepatic
tumors
(
P
=
.
475
)
.
Incidental
CCC
in
liver
transplantation
is
associated
with
poor
outcomes
irrespective
of
tumor
localization
.
Introduction
of
new
adjuvant
multimodal
treatment
concepts
is
necessary
to
improve
the
prognosis
for
this
subgroup
of
patients
.
Diseases
Validation
Diseases presenting
"overall survival"
symptom
cholangiocarcinoma
congenital diaphragmatic hernia
esophageal adenocarcinoma
esophageal carcinoma
esophageal squamous cell carcinoma
hodgkin lymphoma, classical
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom